China Universal Asset Management Company’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.3K | Buy |
12,329
+123
| +1% | +$143 | ﹤0.01% | 457 |
|
|
2025
Q1 | $16.5K | Sell |
12,206
-697
| -5% | -$941 | ﹤0.01% | 461 |
|
|
2024
Q4 | $170K | Buy |
12,903
+1,209
| +10% | +$15.9K | 0.02% | 338 |
|
|
2024
Q3 | $131K | Buy |
11,694
+4,607
| +65% | +$51.6K | 0.01% | 334 |
|
|
2024
Q2 | $76.2K | Sell |
7,087
-4,494
| -39% | -$48.3K | 0.01% | 320 |
|
|
2024
Q1 | $173K | Buy |
11,581
+4,652
| +67% | +$69.3K | 0.02% | 310 |
|
|
2023
Q4 | $125K | Buy |
6,929
+5,400
| +353% | +$97.8K | 0.02% | 253 |
|
|
2023
Q3 | $26.5K | Buy |
1,529
+754
| +97% | +$13.1K | 0.01% | 279 |
|
|
2023
Q2 | $14K | Buy |
775
+2
| +0.3% | +$36 | ﹤0.01% | 298 |
|
|
2023
Q1 | $20.6K | Buy |
773
+278
| +56% | +$7.4K | 0.01% | 217 |
|
|
2022
Q4 | $9.57K | Buy |
495
+39
| +9% | +$754 | ﹤0.01% | 231 |
|
|
2022
Q3 | $10K | Buy |
+456
| New | +$10K | ﹤0.01% | 207 |
|